“…In parallel to emerging imaging technologies, efforts have been concentrated on in vitro organotypic systems of the mammary gland ( Simian et al, 2001 ; Debnath et al, 2003 ; Ewald et al, 2008 , 2012 ). Although multiple organoid models derived from different organs have achieved high levels of complexity and morphological reproducibility of in vivo structures, the complexity of murine mammary organoids is still limited ( Clevers, 2016 ; Kim et al, 2021 ; Vazquez-Armendariz and Herold, 2021 ). Current mammary organoid culture protocols result in either bi-layered sphere-shaped organoids (referred to as cysts) or budding structures upon supplementation with different growth factors, such as FGF2, FGF7, FGF10, and Neuregulin1 ( Fata et al, 2007 ; Nguyen-Ngoc et al, 2015 ; Jardé et al, 2016 ; Sumbal et al, 2020 ).…”